SOUTH SAN FRANCISCO Calif. Sept. 13 2016 PRNewswire &160;Kezar Life Sciences a company focused on the discovery and development of drugs targeting protein homeostasis announced today the initiation of its Phase 1 randomized doubleblind clinical program...
↧